Page last updated: 2024-11-08

ancistrocladidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ancistrocladidine: RN given for unspecified stereoisomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID193880
CHEMBL ID222436
MeSH IDM0420123

Synonyms (6)

Synonym
ancistrocladidine
CHEMBL222436
52659-52-6
7,3'-linked naphthylisoquinoline alkaloid
DTXSID40967087
2-(6,8-dimethoxy-1,3-dimethyl-3,4-dihydroisoquinolin-7-yl)-8-methoxy-3-methylnaphthalen-1-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID401525Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D72004Journal of natural products, May, Volume: 67, Issue:5
Ancistrotanzanine C and related 5,1'- and 7,3'-coupled naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis.
AID401526Antitrypanosomal activity against Trypanosoma cruzi2004Journal of natural products, May, Volume: 67, Issue:5
Ancistrotanzanine C and related 5,1'- and 7,3'-coupled naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis.
AID401527Antitrypanosomal activity against Trypanosoma brucei rhodesiense2004Journal of natural products, May, Volume: 67, Issue:5
Ancistrotanzanine C and related 5,1'- and 7,3'-coupled naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis.
AID401529Cytotoxicity against rat L6 cells2004Journal of natural products, May, Volume: 67, Issue:5
Ancistrotanzanine C and related 5,1'- and 7,3'-coupled naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis.
AID278847Cytotoxicity against J774.1 macrophages after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major.
AID278846Cytotoxicity against cloned virulent Leishmania major promastigotes MHOM/IL/81/FE/BN1 after 48 hrs2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major.
AID401528Antileishmanial activity against Leishmania donovani2004Journal of natural products, May, Volume: 67, Issue:5
Ancistrotanzanine C and related 5,1'- and 7,3'-coupled naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis.
AID278848Cytotoxicity index, IC50 for J774.1 macrophages over IC50 for Leishmania major promastigotes2007Antimicrobial agents and chemotherapy, Jan, Volume: 51, Issue:1
Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major.
AID401524Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K12004Journal of natural products, May, Volume: 67, Issue:5
Ancistrotanzanine C and related 5,1'- and 7,3'-coupled naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.33 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]